The digitization of health care and the technologies that enable this paradigm shift were evident among a couple of pacts that were sealed in May and June. Propeller Health partnered with Aptar Pharma, combining Aptar's know-how in device development with Propeller's experience in digital therapeutics design and implementation, to work with other pharma companies to develop digital medicines. Specifically, they focus on digital technologies for better inhaled, injectable, nasal and dermal delivery of medicines, while providing real-time patient monitoring, to enable personalized treatments. Both Aptar and Propeller have previously teamed up in 2016 to work on a connected metered dose inhaler for respiratory conditions and this most recent agreement is an expansion of their collaboration.
BioSerenity and Pierre Fabre Group have also linked up to develop a connected system of devices - based on special...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?